Mallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA’s inspection schedule

Mallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA’s inspection schedule
fkansteiner
Fri, 02/12/2021 – 11:24